Back to today’s briefing

Story perspectives

Remdesivir Reduces Long COVID Risk in Hospitalized Patients

7/28/2025

39 7

Summary

Story summary

A recent study on hospitalized COVID-19 patients revealed that remdesivir significantly lowers the risk of Long COVID, especially for immunocompromised individuals. This research underscores the heightened vulnerability of these patients and calls for more investigations into antiviral treatments and their impact on post-acute symptoms across different populations and vaccination statuses.

1 of 1

Story summary

A recent study on hospitalized COVID-19 patients revealed that remdesivir significantly lowers the risk of Long COVID, especially for immunocompromised individuals. This research underscores the heightened vulnerability of these patients and calls for more investigations into antiviral treatments and their impact on post-acute symptoms across different populations and vaccination statuses.